These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30146677)

  • 1. Sex Differences in Atrial Fibrillation-Update on Risk Assessment, Treatment, and Long-Term Risk.
    Bai CJ; Madan N; Alshahrani S; Aggarwal NT; Volgman AS
    Curr Treat Options Cardiovasc Med; 2018 Aug; 20(10):79. PubMed ID: 30146677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender in atrial fibrillation: Ten years later.
    Michelena HI; Powell BD; Brady PA; Friedman PA; Ezekowitz MD
    Gend Med; 2010 Jun; 7(3):206-17. PubMed ID: 20638626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women with atrial fibrillation: Greater risk, less attention.
    Volgman AS; Manankil MF; Mookherjee D; Trohman RG
    Gend Med; 2009 Sep; 6(3):419-32. PubMed ID: 19850238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Fibrillation and Ventricular Arrhythmias: Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes.
    Gillis AM
    Circulation; 2017 Feb; 135(6):593-608. PubMed ID: 28153995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants.
    Pancholy SB; Sharma PS; Pancholy DS; Patel TM; Callans DJ; Marchlinski FE
    Am J Cardiol; 2014 Feb; 113(3):485-90. PubMed ID: 24315113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
    Marzona I; Proietti M; Farcomeni A; Romiti GF; Romanazzi I; Raparelli V; Basili S; Lip GYH; Nobili A; Roncaglioni MC
    Int J Cardiol; 2018 Oct; 269():182-191. PubMed ID: 30025657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.
    Ment J
    Vasc Health Risk Manag; 2015; 11():317-32. PubMed ID: 26089678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke prevention in atrial fibrillation: a systematic review.
    Lip GY; Lane DA
    JAMA; 2015 May; 313(19):1950-62. PubMed ID: 25988464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome.
    Humphries KH; Kerr CR; Connolly SJ; Klein G; Boone JA; Green M; Sheldon R; Talajic M; Dorian P; Newman D
    Circulation; 2001 May; 103(19):2365-70. PubMed ID: 11352885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
    Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Management and Outcomes in Men and Women With Nonvalvular Atrial Fibrillation: Data From a Population-Based Cohort.
    Arnson Y; Hoshen M; Berliner Senderey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    JACC Clin Electrophysiol; 2018 May; 4(5):604-614. PubMed ID: 29798787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
    Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
    Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data.
    Kim MH; Xu L; Puckrein G
    Adv Ther; 2018 Nov; 35(11):2069-2080. PubMed ID: 30219991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation.
    Moseley A; Doukky R; Williams KA; Jaffer AK; Volgman AS
    J Womens Health (Larchmt); 2017 Mar; 26(3):214-221. PubMed ID: 27870603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.